Therapeutic Discovery Project Credit

BIO believes that the level of support provided by the TDP simply cannot meet the needs of the growing biotech field. As evidence of the project's popularity suggests, Congress should consider extending or expanding the project in order to support American innovation and speed the development of life-saving cures.

In 2010, the Therapeutic Discovery Project (TDP) awarded $1 billion in tax credits to about 2,923 small biotechnology companies across the country to accelerate discovery of promising, cutting-edge cures to treat devastating diseases like cancer, heart disease, diabetes, and Alzheimer’s.

Emerging biotech companies with promising scientific innovation need a policy environment that will enable them to continue critical research and development of medical advancements and breakthroughs.

Biotechnology is all around us and is already a big part of our lives, providing breakthrough products and technologies to combat disease, reduce our environmental footprint, feed the hungry, and make useful products.

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.